article thumbnail

Where is the opportunity in the therapeutic antibody market?

Drug Discovery World

What you will learn: Where is the opportunity in the mAb market and where is the market heading? What are the main drivers and challenges for the market in the next ten years? The post Where is the opportunity in the therapeutic antibody market? The post Where is the opportunity in the therapeutic antibody market?

Marketing 147
article thumbnail

Where is the opportunity in the therapeutic antibody market?

Drug Discovery World

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. What you will learn: Where is the opportunity in the monoclonal antibody market and where is the market heading? The post Where is the opportunity in the therapeutic antibody market?

Marketing 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Achieving New Heights in Healthcare Marketing With Salesforce Marketing Cloud Personalization

Perficient: Drug Development

In December 2022, the Department of Health and Human Services released a bulletin announcing additional compliance requirements for healthcare marketers when it comes to third-party trackers. The guidance lays forth expectations for how healthcare organizations collect data on activities that take place on their website and mobile apps.

Marketing 122
article thumbnail

Late-stage drug failures drive toxicology testing market growth

Drug Discovery World

The global ADME toxicology testing market is predicted to generate a revenue of $19.21 Factors such as an increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market.

Marketing 147
article thumbnail

Lilly, Novo Nordisk and Vertex lead on market capitalisation growth

Drug Discovery World

market capitalisation growth to $3.67 The top 20 global biopharmaceutical companies experienced varied year-on-year (YoY) market capitalisation shifts in 2023 amid the macroeconomic headwinds, steep patent cliffs and the commencement of US drug price negotiations under the Inflation Reduction Act (IRA).

Marketing 130
article thumbnail

Drug discovery informatics market predicted to grow 12.6% by 2028

Drug Discovery World

The drug discovery informatics market is predicted to grow from $3.77 Drug discovery informatics trends The increasing prevalence of chronic diseases is anticipated to play a large part in driving the expansion of the informatics market. The post Drug discovery informatics market predicted to grow 12.6% billion in 2024 to $6.06

Marketing 130
article thumbnail

Three trends in the antibody-drug conjugate (ADC) market 

Drug Discovery World

A Nature publication confirmed that there are currently 12 FDA-approved ADCs on the market, and nine of these secured FDA approval in the past six years 2. DDW’s Megan Thomas explores three trends in the market. Varying sources suggest that China has been one to watch over recent years and continues to be going forward.

Marketing 245